Description: Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral molecules, complex APIs, orals, iron products, photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems. It provides its products under Orofer, Bevon, Maxtra, Zostum, Metpure, and Eslo brand names. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Home Page: www.emcure.com
Plot No. P-1 and P-2
Pune,
411057
India
Phone:
91 20 3507 0033
Officers
| Name | Title |
|---|---|
| Mr. Satish Ramanlal Mehta | CEO, MD & Executive Director |
| Mr. Tajuddin Sabir Shaikh | Chief Financial Officer |
| Mr. Samit Satish Mehta | President of Operations & Whole-Time Director |
| Dr. Mukund Keshao Gurjar | Chief Scientific Officer & Whole-Time Director |
| Mr. Sunil Rajanikant Mehta | Executive Director of Projects & Whole-Time Director |
| Ms. Namita Vikas Thapar | Executive Director of India Business & Whole-Time Director |
| Mr. Chetan Rajendra Sharma | Company Secretary & Compliance Officer |
| Mr. Naveen Soni | Director of Corporate Communications & Public Relations |
| Mr. Vikas Madan Thapar | President of Corporate Development, Strategy & Finance |
| Mr. Rajesh Nair | President of HR |
Exchange: BSE
Country: IN : India
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |